Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,732 | -84,553 | -36,120 | -22,509 | -2,673 |
| Depreciation Amortization | 1,546 | 6,467 | 4,821 | 3,051 | 1,437 |
| Accounts receivable | -8,157 | -184 | -21,031 | -604 | -684 |
| Accounts payable and accrued liabilities | -2,002 | -821 | -3,576 | 5,768 | 4,552 |
| Other Working Capital | -27,880 | -61,078 | -80,752 | -49,121 | -26,786 |
| Other Operating Activity | 18,303 | 44,368 | 52,117 | 12,300 | 624 |
| Operating Cash Flow | $-38,922 | $-95,801 | $-84,541 | $-51,115 | $-23,530 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -278,964 | -193,964 | -180,523 | 13,600 |
| PPE Investments | -4,271 | -11,952 | -10,067 | -7,929 | -4,320 |
| Sale Of Investment | 34,429 | 50,138 | 29,148 | 19,603 | N/A |
| Investing Cash Flow | $30,158 | $-240,778 | $-174,883 | $-168,849 | $9,280 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,102 | 257,948 | 256,943 | 254,811 | 253,478 |
| Financing Cash Flow | $5,102 | $257,948 | $256,943 | $254,811 | $253,478 |
| Exchange Rate Effect | N/A | 410 | N/A | N/A | N/A |
| Beginning Cash Position | 143,583 | 221,804 | 221,804 | 221,804 | 221,804 |
| End Cash Position | 139,921 | 143,583 | 219,323 | 256,651 | 461,032 |
| Net Cash Flow | $-3,662 | $-78,221 | $-2,481 | $34,847 | $239,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,922 | -95,801 | -84,541 | -51,115 | -23,530 |
| Capital Expenditure | -4,271 | -11,952 | -10,067 | -7,929 | -4,320 |
| Free Cash Flow | -43,193 | -107,753 | -94,608 | -59,044 | -27,850 |